Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease

NCT: NCT06380075 · RECRUITING

NCT IDNCT06380075
StatusRECRUITING
Start Date2024-08-29
Completion2026-12

Brief Summary

The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retinal diseases (IRDs). Participants will: * undergo pupillary dilation * have photographs taken of the inside of the eyes using three different cameras

Frequently Asked Questions

What is COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease?

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease is a clinical trial registered under NCT06380075. Current status: RECRUITING.

What is the status of NCT06380075?

The current status of NCT06380075 (COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease) is: RECRUITING.

When did COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease start?

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease started on 2024-08-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.